UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Kinase Fusion Gene:ROR1_SNAP25 |
Kinase Fusion Protein Summary |
Kinase Fusion gene summary |
Kinase Fusion partner gene information | Kinase Fusion gene name: ROR1_SNAP25 | KinaseFusionDB ID: KFG5474 | FusionGDB2.0 ID: KFG5474 | Hgene | Tgene | Gene symbol | ROR1 | SNAP25 | Gene ID | 6095 | 6616 | |
Gene name | RAR related orphan receptor A | synaptosome associated protein 25 | ||||||||||
Synonyms | IDDECA|NR1F1|ROR1|ROR2|ROR3|RORa1|RORalpha|RZR-ALPHA|RZRA | CMS18|RIC-4|RIC4|SEC9|SNAP|SNAP-25|SUP|bA416N4.2|dJ1068F16.2 | ||||||||||
Cytomap | 15q22.2 | 20p12.2 | ||||||||||
Type of gene | protein-coding | protein-coding | ||||||||||
Description | nuclear receptor ROR-alphaRAR-related orphan nuclear receptor alphaROR-alphanuclear receptor RZR-alphanuclear receptor subfamily 1 group F member 1retinoic acid receptor-related orphan receptor alpharetinoid-related orphan receptor alphatranscripti | synaptosomal-associated protein 25resistance to inhibitors of cholinesterase 4 homologsynaptosomal-associated protein, 25kDasynaptosome associated protein 25kDa | ||||||||||
Modification date | 20240403 | 20240407 | ||||||||||
UniProtAcc | Q01973 | P60880 | ||||||||||
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000371079, ENST00000371080, ENST00000482426, ENST00000545203, | ENST00000254976, ENST00000304886, ENST00000495883, | |||||||||
Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: ROR1 [Title/Abstract] AND SNAP25 [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ROR1(64286029)-SNAP25(10287852), # samples:1 |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ROR1 | GO:0006355 | regulation of DNA-templated transcription | 9328355 |
Hgene | ROR1 | GO:0030522 | intracellular receptor signaling pathway | 19965867 |
Hgene | ROR1 | GO:0036315 | cellular response to sterol | 19965867 |
Hgene | ROR1 | GO:0045893 | positive regulation of DNA-templated transcription | 7926749 |
Hgene | ROR1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 17545671|19955433 |
Kinase Fusion gene breakpoints across ROR1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Kinase Fusion gene breakpoints across SNAP25 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
Kinase Fusion gene information. |
Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
ChiTaRS5.0 | AW899942 | ROR1 | chr1 | 64286029 | SNAP25 | chr20 | 10287852 |
Top |
Kinase Fusion ORF Analysis |
Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:64286029/:10287852) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ROR1 | SNAP25 |
FUNCTION: Has very low kinase activity in vitro and is unlikely to function as a tyrosine kinase in vivo (PubMed:25029443). Receptor for ligand WNT5A which activate downstream NFkB signaling pathway and may result in the inhibition of WNT3A-mediated signaling (PubMed:25029443, PubMed:27162350). In inner ear, crucial for spiral ganglion neurons to innervate auditory hair cells (PubMed:27162350). {ECO:0000269|PubMed:25029443, ECO:0000269|PubMed:27162350}. | FUNCTION: t-SNARE involved in the molecular regulation of neurotransmitter release. May play an important role in the synaptic function of specific neuronal systems. Associates with proteins involved in vesicle docking and membrane fusion. Regulates plasma membrane recycling through its interaction with CENPF. Modulates the gating characteristics of the delayed rectifier voltage-dependent potassium channel KCNB1 in pancreatic beta cells. {ECO:0000250|UniProtKB:P60881}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
- Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of ROR1_SNAP25 |
Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
ROR1 | Q01973 | human | ERBB3 | P21860 | Y1307 | HQAPHVHyARLKtLR |
Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
Enriched GO biological processes of the phosphorylation target genes of the kinase |
Kinase | GOID | GO term | P.adjust |
ROR1 | ID | Description | 0.00e+00 |
ROR1 | GO:2000672 | negative regulation of motor neuron apoptotic process | 7.49e-03 |
ROR1 | GO:2000671 | regulation of motor neuron apoptotic process | 7.49e-03 |
ROR1 | GO:0016202 | regulation of striated muscle tissue development | 7.49e-03 |
ROR1 | GO:0038128 | ERBB2 signaling pathway | 7.49e-03 |
ROR1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade | 7.49e-03 |
ROR1 | GO:0097049 | motor neuron apoptotic process | 7.49e-03 |
ROR1 | GO:0106058 | positive regulation of calcineurin-mediated signaling | 7.49e-03 |
ROR1 | GO:0048634 | regulation of muscle organ development | 7.49e-03 |
ROR1 | GO:1901863 | positive regulation of muscle tissue development | 7.49e-03 |
ROR1 | GO:0061098 | positive regulation of protein tyrosine kinase activity | 7.93e-03 |
ROR1 | GO:0014037 | Schwann cell differentiation | 7.93e-03 |
ROR1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade | 7.93e-03 |
ROR1 | GO:0106056 | regulation of calcineurin-mediated signaling | 7.93e-03 |
ROR1 | GO:0050850 | positive regulation of calcium-mediated signaling | 7.93e-03 |
ROR1 | GO:0033173 | calcineurin-NFAT signaling cascade | 7.93e-03 |
ROR1 | GO:1901861 | regulation of muscle tissue development | 7.93e-03 |
ROR1 | GO:0097720 | calcineurin-mediated signaling | 7.93e-03 |
ROR1 | GO:0003197 | endocardial cushion development | 8.11e-03 |
ROR1 | GO:0061097 | regulation of protein tyrosine kinase activity | 8.28e-03 |
ROR1 | GO:0021545 | cranial nerve development | 8.55e-03 |
ROR1 | GO:0038034 | signal transduction in absence of ligand | 8.55e-03 |
ROR1 | GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 8.55e-03 |
ROR1 | GO:0007422 | peripheral nervous system development | 9.71e-03 |
ROR1 | GO:0050848 | regulation of calcium-mediated signaling | 9.71e-03 |
ROR1 | GO:0021675 | nerve development | 1.09e-02 |
ROR1 | GO:0038127 | ERBB signaling pathway | 1.34e-02 |
ROR1 | GO:0043524 | negative regulation of neuron apoptotic process | 1.61e-02 |
ROR1 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 1.61e-02 |
ROR1 | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1.61e-02 |
ROR1 | GO:0051048 | negative regulation of secretion | 1.61e-02 |
ROR1 | GO:0019722 | calcium-mediated signaling | 1.89e-02 |
ROR1 | GO:0097191 | extrinsic apoptotic signaling pathway | 1.89e-02 |
ROR1 | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 1.89e-02 |
ROR1 | GO:0043523 | regulation of neuron apoptotic process | 1.89e-02 |
ROR1 | GO:0048738 | cardiac muscle tissue development | 1.89e-02 |
ROR1 | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1.89e-02 |
ROR1 | GO:0010001 | glial cell differentiation | 1.89e-02 |
ROR1 | GO:0014706 | striated muscle tissue development | 1.89e-02 |
ROR1 | GO:0018108 | peptidyl-tyrosine phosphorylation | 1.89e-02 |
ROR1 | GO:0018212 | peptidyl-tyrosine modification | 1.89e-02 |
ROR1 | GO:0051402 | neuron apoptotic process | 1.89e-02 |
ROR1 | GO:0045860 | positive regulation of protein kinase activity | 1.89e-02 |
ROR1 | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1.89e-02 |
ROR1 | GO:0019932 | second-messenger-mediated signaling | 1.95e-02 |
ROR1 | GO:0007162 | negative regulation of cell adhesion | 1.95e-02 |
ROR1 | GO:0060485 | mesenchyme development | 1.98e-02 |
ROR1 | GO:0033674 | positive regulation of kinase activity | 1.98e-02 |
ROR1 | GO:0042063 | gliogenesis | 1.98e-02 |
ROR1 | GO:0007517 | muscle organ development | 2.03e-02 |
Top |
Related Drugs to ROR1_SNAP25 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Distribution of the number of studies mentioning ROR1-SNAP25 and kinase inhibitors the PubMed Abstract (04-01-2024) |
Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to ROR1_SNAP25 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
MeSH ID | MeSH term |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
Clinical Trials from clinicaltrials.gov (06-17-2024) |
Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |